Chlamydia Prevalence and Testing Project - a randomised controlled trial
Chlamydia prevalence and testing program targetting women aged 16 to 24 years in general practice
University of Melbourne
12 participants
May 15, 2008
Interventional
Conditions
Summary
To determine whether a $5 incentive payment will lead to increased chlamydia testing rates by general practitioners.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The intervention will be in place for 6 months. GPs will be expected to conduct chlamydia screening during a routine consultation with an eligible patient. Screening involves requesting a chlamydia test for the patient. It should take a couple of minutes to discuss with the patient during the consultation
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000499381